<?xml version="1.0"?>
<rss version="2.0">
<channel>
<title>Healthcare Industry Today: Drug-Coated Heart Stents News</title>
<link>http://health.einnews.com/news/drug-eluting-coronary-stents</link><description>Constantly updated news and information about healthcare industry.</description><item>
<title>XIENCE V Drug Eluting Stent from Abbott</title>
<link>http://health.einnews.com/news.php?wid=170129200</link>
<pubDate>16 May 2008 00:35 GMT</pubDate>
<description>
...  studying the XIENCE(tm) V Everolimus Eluting Coronary Stent System, demonstrated that XIENCE V continues to  ...  year, driven by numerically lower rates of heart attacks and lower observed rates of re-intervention  ...  eliminate variability in the definitions across various drug eluting stent trials. &quot;From these results, it is  ...
</description>
</item><item>
<title>Cypher Stent Ad Criticized</title>
<link>http://health.einnews.com/news.php?wid=170092093</link>
<pubDate>15 May 2008 19:38 GMT</pubDate>
<description>
...  about the potential dangers of receiving a stent, according to an article published by The  ...  words. Stents are an important element in heart-disease treatment. Tiny wire-mesh tubes, stents prop open  ...  and there is long, ongoing debate over drug-coated versus bare metal stent use. (FDA) should  ...
</description>
</item><item>
<title>Evolving Treatments for COPD Emphasizing Innovative Therapies</title>
<link>http://health.einnews.com/news.php?wid=170084062</link>
<pubDate>15 May 2008 19:12 GMT</pubDate>
<description>
...  chronic pulmonary obstructive disease (COPD) rivals congestive heart failure as a major healthcare challenge. Primarily  ...  antagonists and receptor agonists. Interventional approaches include drug-eluting bronchial stents and minimally invasive devices. These findings are  ...
</description>
</item><item>
<title>Study finds new generation of drug-coated stent benefits heart patients</title>
<link>http://health.einnews.com/news.php?wid=170083143</link>
<pubDate>15 May 2008 18:38 GMT</pubDate>
<description>
... A two-year study comparing a new generation drug-coated stent, XIENCE, with a currently used drug eluting stent, TAXUS, has found that the XIENCE stent had superior benefits in more than  ...
</description>
</item><item>
<title>First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System</title>
<link>http://health.einnews.com/news.php?wid=170078834</link>
<pubDate>15 May 2008 18:12 GMT</pubDate>
<description>
...  near a narrowing that required a coronary stent for the usual reasons. Because of the  ...  type of stent -- bare metal or drug-eluting - is best for the patient.&quot; The  ...  way in providing information to help prevent heart attacks in the near future.&quot; Coronary artery  ...
</description>
</item><item>
<title>Abbott reports two-year data for Xience V</title>
<link>http://health.einnews.com/news.php?wid=170072947</link>
<pubDate>15 May 2008 17:36 GMT</pubDate>
<description>
...  for its Xience V everlolimus eluting coronary stent system,a next-generation drug-eluting stent intended for use in the treatment  ...  reduction reduction in the risk of adverse cardiac events and a 32% reduction in the  ...
</description>
</item><item>
<title>International Endeavor Registry Reports Safety and Performance of Medtronic Drug-Eluting Stent in Diverse Patient Population</title>
<link>http://health.einnews.com/news.php?wid=170071049</link>
<pubDate>15 May 2008 17:16 GMT</pubDate>
<description>
...  Registry Reports Safety and Performance of Medtronic Drug-Eluting Stent in Diverse Patient Population E-Five Results on  ...  Also Presented at European Meeting of Interventional Cardiologists New data presented today at EuroPCR reports  ...
</description>
</item><item>
<title>Buffalo cardiologist leads criticism of marketing medical products to patients</title>
<link>http://health.einnews.com/news.php?wid=170043766</link>
<pubDate>15 May 2008 14:17 GMT</pubDate>
<description>
...  Life Wide Open campaign for the Cypher heart stent, which also included spots in newspapers and  ...  review of studies by researchers showing that drug-coated stents do not pose a higher risk  ...
</description>
</item><item>
<title>Medical product ads under scrutiny</title>
<link>http://health.einnews.com/news.php?wid=170026623</link>
<pubDate>15 May 2008 12:18 GMT</pubDate>
<description>
...  Life Wide Open campaign for the Cypher heart stent, which also included spots in newspapers and  ...  review of studies by researchers showing that drug-coated stents do not pose a higher risk  ...
</description>
</item><item>
<title>Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeich&apos;s Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents</title>
<link>http://health.einnews.com/news.php?wid=170023200</link>
<pubDate>15 May 2008 12:13 GMT</pubDate>
<description>
...  use of the company&apos;s Genous Bio-engineered R stent, the world&apos;s first pro-healing stent, as a  ...  pro-healing stent, as a safe alternative to drug-eluting stents. Presented by Robbert de Winter, M.D.,  ...  23 mm) and/or chronic total occlusions. &quot;Interventional cardiologists need better stent technologies,&quot; said de Winter,  ...
</description>
</item><item>
<title>Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeich&apos;s Genous(TM) Bio-engi</title>
<link>http://health.einnews.com/news.php?wid=170023015</link>
<pubDate>15 May 2008 12:12 GMT</pubDate>
<description>
...  Support Use of OrbusNeich&apos;s Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents Multiple Clinical Data Presentations at EuroPCR  ...  23 mm) and/or chronic total occlusions. &quot;Interventional cardiologists need better stent technologies,&quot; said de Winter,  ...
</description>
</item><item>
<title>Endeavor II Four-Year Results Demonstrate Long-Term Safety And Durable Efficacy Of Medtronic Drug-Eluting Stent</title>
<link>http://health.einnews.com/news.php?wid=170010429</link>
<pubDate>15 May 2008 09:57 GMT</pubDate>
<description>
...  durable efficacy of the company&apos;s Endeavor Zotarolimus-Eluting Coronary Stent System for the treatment of coronary artery  ...  Fajadet of the Clinique Pasteur Unit de Cardiologie Interventionnelle in Tolouse, France, who presented the  ...
</description>
</item><item>
<title>Medtronic Begins International Study of Stent</title>
<link>http://health.einnews.com/news.php?wid=169995727</link>
<pubDate>15 May 2008 08:26 GMT</pubDate>
<description>
...  comparing the company&apos;s Endeavor Resolute Zotarolimus-Eluting Coronary Stent with Abbott Laboratory&apos;s Xience V Everolimus-Eluting Coronary  ...  April 30. Prof. Sigmund Silber of the Heart Catheterization Centre in Munich, Germany, and Prof.  ...  is the trial for the Endeavor Resolute drug-eluting stent and one part of the comprehensive  ...
</description>
</item><item>
<title>XIENCE&amp;trade; V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years</title>
<link>http://health.einnews.com/news.php?wid=169991534</link>
<pubDate>15 May 2008 07:46 GMT</pubDate>
<description>
...  studying the XIENCE&amp;trade; V Everolimus Eluting Coronary Stent System, demonstrated that XIENCE V continues to  ...  year, driven by numerically lower rates of heart attacks and lower observed rates of re-intervention  ...  eliminate variability in the definitions across various drug eluting stent trials. &quot;From these results, it is  ...
</description>
</item><item>
<title>(SMT) PAINT Trial Results Support Safety and Efficacy of the Infinnium and Supralimus Stents (none)</title>
<link>http://health.einnews.com/news.php?wid=169981250</link>
<pubDate>15 May 2008 06:16 GMT</pubDate>
<description>
...  and Efficacy of the Infinnium and Supralimus Stents (none) Published on: May 15th, 2008 12:01am  ...  Surat, India, leading developer and manufacturer of drug-eluting stents, welcomed the positive results of the  ...  Primary investigator, Dr Pedro Lemos of the Heart Institute (InCor) University of So Paulo Medical  ...
</description>
</item></channel>
</rss>
